The World's #1 Mining Property Marketplace

Established 2009 — Connecting Buyers and Sellers Worldwide

Moberg Pharma Divests Balmex® for $4.25 Million

STOCKHOLM, Feb. 28, 2018 /PRNewswire/ —
Moberg Pharma AB (OMX: MOB) has entered into an agreement with Randob Labs to divest the brand Balmex® for a total consideration of $4.25 million (34.6 million SEK) plus the inventory value at closing. The divestment is expected to result in a…